BioSphere Pitches Uterine Fibroid Embolization Alternative To Hysterectomy

BioSphere Medical maintains that 180,000 additional women per year who would normally receive hysterectomies will be candidates for its Embosphere Microspheres uterine fibroid embolization now that the procedure has received FDA go-ahead